Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer
- PMID: 22592210
- DOI: 10.1097/JTO.0b013e31824cbad8
Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer
Abstract
Objective: This study investigated the factors predicting recurrence and death in patients with resected stage-I non-small-cell lung cancers according to the 7th edition of tumor, node, metastasis (TNM) classification for lung cancer.
Methods: All patients undergoing surgical resection for pathological stage-I non-small-cell lung cancers at Taipei Veterans General Hospital between 1980 and 2000 were retrospectively reviewed. Those undergoing sublobar resection were excluded. The factors predicting overall survival (OS), overall recurrence, local recurrence, and distant metastasis were investigated.
Results: A total of 756 patients were eligible. The 5-year OS rate and probability of freedom from recurrence were 57.3% and 70.2%, respectively. The 2-year local-recurrence-free and distant-metastasis-free rates were 90.7% and 82.1%, respectively. In multivariable analysis, the new T descriptor (T1a, T1b, and T2a) was the common factor that significantly affected OS (p = 0.003), overall recurrence (p = 0.004), and distant metastasis (p < 0.001). Smoking index more than 20, and number of mediastinal lymph nodes dissected/sampled of 15 or fewer were common factors that significantly predicted worse OS (p < 0.001, p < 0.001, respectively), lower probability of freedom from overall recurrence (p = 0.025, p = 0.009, respectively), and higher risk of local recurrence (p < 0.001, p = 0.030, respectively). Non-squamous-cell histology predicted higher risk of distant metastasis (p = 0.006).
Conclusions: Risks of death and recurrence increase as the T descriptor upgrades in the new TNM system. The combination of risk factors can be used to identify high-risk subgroups of local recurrence and distant metastasis.
Similar articles
-
Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer.J Thorac Oncol. 2012 Feb;7(2):397-405. doi: 10.1097/JTO.0b013e31823b564a. J Thorac Oncol. 2012. PMID: 22173701
-
Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.J Thorac Oncol. 2012 Jul;7(7):1141-7. doi: 10.1097/JTO.0b013e3182519a42. J Thorac Oncol. 2012. PMID: 22617241
-
Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.Cancer. 2009 Feb 15;115(4):851-8. doi: 10.1002/cncr.23985. Cancer. 2009. PMID: 19140203
-
Positive pre-resection pleural lavage cytology is associated with increased risk of lung cancer recurrence in patients undergoing surgical resection: a meta-analysis of 4450 patients.Thorax. 2012 Jun;67(6):526-32. doi: 10.1136/thoraxjnl-2011-200424. Epub 2012 Jan 27. Thorax. 2012. PMID: 22286928
-
Long-term survival following surgical treatment of solitary brain metastasis in non-small cell lung cancer.Chest. 1996 Jan;109(1):271-6. doi: 10.1378/chest.109.1.271. Chest. 1996. PMID: 8549197 Review.
Cited by
-
Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma.Cancer Med. 2023 Apr;12(8):9547-9558. doi: 10.1002/cam4.5731. Epub 2023 Mar 6. Cancer Med. 2023. PMID: 36880167 Free PMC article.
-
[Pattern of Recurrence and Metastasis after Radical Resection of Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi. 2022 Jan 20;25(1):26-33. doi: 10.3779/j.issn.1009-3419.2021.102.50. Zhongguo Fei Ai Za Zhi. 2022. PMID: 35078282 Free PMC article. Chinese.
-
Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection.Front Oncol. 2021 Sep 1;11:711206. doi: 10.3389/fonc.2021.711206. eCollection 2021. Front Oncol. 2021. PMID: 34540678 Free PMC article.
-
Survival Prediction Model Using Clinico-Pathologic Characteristics for Nonsmall Cell Lung Cancer Patients After Curative Resection.Medicine (Baltimore). 2015 Nov;94(45):e2013. doi: 10.1097/MD.0000000000002013. Medicine (Baltimore). 2015. PMID: 26559298 Free PMC article.
-
Pretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysis.BMC Cancer. 2024 Apr 18;24(1):495. doi: 10.1186/s12885-024-12267-w. BMC Cancer. 2024. PMID: 38637726 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical